| Year |
Citation |
Score |
| 2012 |
Kerr EH, Hameed O, Lewis JS, Bartolucci AA, Wang D, Said-Al-Naief N. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. International Journal of Surgical Pathology. 20: 37-46. PMID 21862490 DOI: 10.1177/1066896911417970 |
0.303 |
|
| 2010 |
Singh KP, Bartolucci AA, Bae S. The Bayesian Multiple Logistic Random Effects Model for Analysis of Clinical Trial Data Journal of Data Science. 8: 495-504. DOI: 10.6339/Jds.2010.08(3).606 |
0.318 |
|
| 2009 |
Zheng S, Rao U, Bartolucci AA, Singh KP. Random Regression Models Based On The Skew Elliptically Contoured Distribution Assumptions With Applications To Longitudinal Data. Journal of Applied Probability and Statistics. 4: 21-32. PMID 21637734 DOI: 10.22237/Jmasm/1067645340 |
0.577 |
|
| 2008 |
Bartolucci AA, Bae S, Singh KP. Establishing a Bayesian predictive survival model adjusting for random effects Mathematics and Computers in Simulation. 78: 328-334. DOI: 10.1016/J.Matcom.2008.01.035 |
0.314 |
|
| 2004 |
Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ. Chiari I malformation and neurofibromatosis type 1. Pediatric Neurology. 30: 278-80. PMID 15087107 DOI: 10.1016/J.Pediatrneurol.2003.09.013 |
0.3 |
|
| 2001 |
Kim EM, Sivanandham M, Stavropoulos CI, Bartolucci AA, Wallack MK. Overview analysis of adjuvant therapies for melanoma - A special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials Surgical Oncology. 10: 53-59. PMID 11719029 DOI: 10.1016/S0960-7404(01)00020-2 |
0.308 |
|
| 1998 |
Karakousis CP, Balch CM, Bartolucci A, Driscoll DL. Is the capacity for lymph node-mediated distant dissemination the same for all nodal groups in malignant melanoma? Melanoma Research. 8: 419-424. PMID 9835455 DOI: 10.1097/00008390-199810000-00006 |
0.317 |
|
| 1998 |
Ragde H, Elgamal AAA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma Cancer. 83: 989-1001. PMID 9731904 DOI: 10.1002/(Sici)1097-0142(19980901)83:5<989::Aid-Cncr26>3.0.Co;2-Q |
0.321 |
|
| 1998 |
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. Journal of the American College of Surgeons. 187: 69-77; discussion 77. PMID 9660028 DOI: 10.1016/S1072-7515(98)00097-0 |
0.334 |
|
| 1997 |
Berman E, Wiernik P, Vogler R, Vélez-Gárcia E, Bartolucci A, Whaley FS. Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia. Cancer. 80: 2181-5. PMID 9395031 DOI: 10.1002/(Sici)1097-0142(19971201)80:11+<2181::Aid-Cncr3>3.0.Co;2-L |
0.319 |
|
| 1997 |
Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Annals of Surgery. 226: 198-206. PMID 9296514 DOI: 10.1097/00000658-199708000-00012 |
0.301 |
|
| 1997 |
Tanner J, Craig C, Bartolucci A, Allon M, Fox L, Geiger B, Wilson N. The Effect of a Patient Self-Monitoring Tool Upon Adherence in Patients Receiving Hemodialysis Journal of the American Dietetic Association. 97: A60. DOI: 10.1016/S0002-8223(97)00524-5 |
0.308 |
|
| 1996 |
Wallack MK, Sivanandham M, Whooley B, Ditaranto K, Bartolucci AA. Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial Annals of Surgical Oncology : the Official Journal of the Society of Surgical Oncology. 3: 110-117. PMID 8646509 DOI: 10.1007/Bf02305788 |
0.346 |
|
| 1996 |
Schmidt JD, Gibbons RP, Murphy GP, Bartolucci A. Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation. Investigators of the National Prostate Cancer Project. The Prostate. 28: 51-7. PMID 8545281 DOI: 10.1002/(Sici)1097-0045(199601)28:1<51::Aid-Pros7>3.0.Co;2-R |
0.325 |
|
| 1995 |
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA. A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer. 75: 34-42. PMID 7804974 DOI: 10.1002/1097-0142(19950101)75:1<34::Aid-Cncr2820750108>3.0.Co;2-0 |
0.35 |
|
| 1994 |
Omura GA, Vogler WR, Martelo O, Gordon DS, Bartolucci AA. Late intensification therapy in adult acute lymphoid leukemia: Long-term follow-up of the southeastern cancer study group experience Leukemia and Lymphoma. 15: 71-78. PMID 7858504 DOI: 10.3109/10428199409051680 |
0.33 |
|
| 1993 |
Johnson DH, Bass D, Einhorn LH, Crawford J, Perez CA, Bartolucci A, Omura GA, Greco FA. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 11: 1223-9. PMID 8391064 DOI: 10.1200/Jco.1993.11.7.1223 |
0.301 |
|
| 1991 |
Lipton A, Harvey HA, Balch CM, Antle CE, Heckard R, Bartolucci AA. Corynebacterium parvum versus bacille calmette-guérin adjuvant immunotherapy of stage II malignant melanoma Journal of Clinical Oncology. 9: 1151-1156. PMID 2045856 DOI: 10.1200/Jco.1991.9.7.1151 |
0.349 |
|
| 1990 |
Luedke DW, Einhorn L, Omura GA, Sarma PR, Bartolucci AA, Birch R, Greco FA. Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: A southeastern cancer study group trial Journal of Clinical Oncology. 8: 886-891. PMID 2159054 DOI: 10.1200/Jco.1990.8.5.886 |
0.332 |
|
| 1989 |
Schmidt JD, Gibbons RP, Bartolucci A, Murphy GP. Prognosis in stage D-1 prostate cancer relative to anatomic sites of nodal metastases. National Prostatic Cancer Treatment Group. Cancer. 64: 1743-6. PMID 2790688 DOI: 10.1002/1097-0142(19891015)64:8<1743::Aid-Cncr2820640831>3.0.Co;2-U |
0.316 |
|
| 1987 |
Wallack MK, Bash JA, Leftheriotis E, Seigler H, Bland K, Wanebo H, Balch C, Bartolucci AA. Positive Relationship of Clinical and Serologic Responses to Vaccinia Melanoma Oncolysate Archives of Surgery. 122: 1460-1463. PMID 3689123 DOI: 10.1001/Archsurg.1987.01400240108020 |
0.339 |
|
| 1986 |
Wallack MK, McNally KR, Leftheriotis E, Seigler H, Balch C, Wanebo H, Bartolucci AA, Bash JA. A Southeastern Cancer Study Group Phase I/II trial with vaccinia melanoma oncolysates Cancer. 57: 649-655. PMID 3943002 DOI: 10.1002/1097-0142(19860201)57:3<649::Aid-Cncr2820570342>3.0.Co;2-6 |
0.302 |
|
| 1986 |
DeSimone P, Kramer B, Omura GA, Bartolucci AA. Phase II evaluation of diaziquone in gastric and pancreatic cancers. A southeastern cancer study group trial American Journal of Clinical Oncology: Cancer Clinical Trials. 9: 401-402. PMID 3776902 DOI: 10.1097/00000421-198610000-00008 |
0.308 |
|
| 1986 |
Keller JW, Knospe WH, Raney M, Huguley CM, Johnson L, Bartolucci AA, Omura GA. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. A Southeastern Cancer Study Group trial Cancer. 58: 1185-1192. PMID 3527402 DOI: 10.1002/1097-0142(19860915)58:6<1185::Aid-Cncr2820580602>3.0.Co;2-H |
0.31 |
|
| 1986 |
Gams RA, Omura GA, Velez-Garcia E, Kellermeyer R, Raney M, Bartolucci AA. Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial Cancer. 58: 1963-1968. PMID 2428462 DOI: 10.1002/1097-0142(19861101)58:9<1963::Aid-Cncr2820580902>3.0.Co;2-P |
0.302 |
|
| 1985 |
Cohen HJ, Bartolucci A. Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience. The American Journal of Medicine. 79: 316-24. PMID 3898836 DOI: 10.1016/0002-9343(85)90310-9 |
0.345 |
|
| 1985 |
Gams RA, Rainey M, Dandy M, Bartolucci AA, Silberman H, Omura G. Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: A Southeastern Cancer Study Group Trial Journal of Clinical Oncology. 3: 1188-1195. PMID 3897470 DOI: 10.1200/Jco.1985.3.9.1188 |
0.304 |
|
| 1984 |
Presant CA, Denes AE, Liu C, Bartolucci AA. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine. Cancer. 53: 2610-4. PMID 6372981 DOI: 10.1002/1097-0142(19840615)53:12<2610::Aid-Cncr2820531207>3.0.Co;2-9 |
0.348 |
|
| 1984 |
Presant CA, Bartolucci AA, Lowenbraun S. Effects of amphotericin B on combination chemotherapy of metastatic sarcomas Cancer. 53: 214-218. PMID 6360332 DOI: 10.1002/1097-0142(19840115)53:2<214::Aid-Cncr2820530205>3.0.Co;2-K |
0.334 |
|
| 1983 |
Cohen HJ, Silberman HR, Forman W, Bartolucci A, Liu C. Effects of age on responses to treatment and survival of patients with multiple myeloma. Journal of the American Geriatrics Society. 31: 272-7. PMID 6841855 DOI: 10.1111/J.1532-5415.1983.Tb04870.X |
0.333 |
|
| 1983 |
Smalley RV, Lefante J, Bartolucci A, Carpenter J, Vogel C, Krauss S. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. Breast Cancer Research and Treatment. 3: 209-220. PMID 6688538 DOI: 10.1007/Bf01803563 |
0.323 |
|
| 1983 |
Smalley RV, Bartolucci AA, Moore M, Vogel C, Carpenter J, Perez CA, Velez-Garcia E, Marcial V, Lefante J, Wittliff J, Ketcham AA, Durant J. Southeastern cancer study group: Breast cancer studies 1972-1982 International Journal of Radiation Oncology, Biology, Physics. 9: 1867-1874. PMID 6607245 DOI: 10.1016/0360-3016(83)90354-1 |
0.332 |
|
| 1983 |
Bartolucci AA, Liu C, Durant JR, Gams RA. Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease Cancer. 52: 2209-2213. PMID 6580060 DOI: 10.1002/1097-0142(19831215)52:12<2209::Aid-Cncr2820521206>3.0.Co;2-6 |
0.324 |
|
| 1983 |
Enrique V, Moore M, Vogel CL, Marcial V, Ketcham A, Bartolucci A, Liu C, Smalley R. Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience. Breast Cancer Research and Treatment. 3. PMID 6367861 DOI: 10.1007/Bf01855128 |
0.325 |
|
| 1983 |
Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treaments Annals of Surgery. 198: 164-167. PMID 6347102 DOI: 10.1097/00000658-198308000-00009 |
0.339 |
|
| 1983 |
Nathwani B, Metter G, Gams R, Bartolucci A, Hartsock R, Neiman R, Byrne GJ, Barcos M, Kim H, Rappaport H. Malignant lymphoma, mixed cell type, diffuse Blood. 62: 200-208. DOI: 10.1182/Blood.V62.1.200.200 |
0.329 |
|
| 1982 |
Balch CM, Smalley RV, Bartolucci AA, Burns D, Presant CA, Durant JR. A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage 1): Prognostic factors analysis and preliminary results of immunotherapy Cancer. 49: 1079-1084. PMID 7037155 DOI: 10.1002/1097-0142(19820315)49:6<1079::Aid-Cncr2820490604>3.0.Co;2-X |
0.364 |
|
| 1982 |
Cohen HJ, Bartolucci AA. Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma American Journal of Clinical Oncology: Cancer Clinical Trials. 5: 21-27. PMID 6805305 DOI: 10.1097/00000421-198202000-00004 |
0.33 |
|
| 1982 |
Presant CA, Bartolucci AA. Prognostic factors in metastatic malignant melanoma. The Southeastern Cancer Study Group experience Cancer. 49: 2192-2196. PMID 6176309 DOI: 10.1002/1097-0142(19820515)49:10<2192::Aid-Cncr2820491035>3.0.Co;2-R |
0.324 |
|
| 1981 |
Durant JR, Bartolucci AA, Birch R. Importance of stratification in later stages of clinical trials Controlled Clinical Trials. 2: 319-325. PMID 7333107 DOI: 10.1016/0197-2456(81)90021-0 |
0.305 |
|
| 1981 |
Presant CA, Lowenbraun S, Bartolucci AA, Smalley RV. Metastatic sarcomas: Chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine Cancer. 47: 457-465. PMID 7225999 DOI: 10.1002/1097-0142(19810201)47:3<457::Aid-Cncr2820470306>3.0.Co;2-G |
0.305 |
|
| 1981 |
Perez CA, Krauss S, Bartolucci AA, Durant JR, Lowenbraun S, Salter MM, Storaalsi J, Kellermeyer R, Comas F. Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the Southeastern Cancer Study Group Cancer. 47: 2407-2413. PMID 6268269 DOI: 10.1002/1097-0142(19810515)47:10<2407::Aid-Cncr2820471015>3.0.Co;2-R |
0.337 |
|
| 1980 |
Robert F, Omura G, Bartolucci AA. Combination chemotherapy with cyclophosphamide, adriamycin, intermediate dose methotrexate, and folinic acid rescue (CAMF) in advanced lung cancer Cancer. 45: 1-5. PMID 6985825 DOI: 10.1002/1097-0142(19800101)45:1<1::Aid-Cncr2820450102>3.0.Co;2-F |
0.312 |
|
| 1979 |
Cohen HJ, Silberman HR, Larsen WE, Johnson L, Bartolucci AA, Durant JR. Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma Blood. 54: 824-836. PMID 476303 DOI: 10.1182/Blood.V54.4.824.824 |
0.35 |
|
| 1978 |
Durant JR, Gams RA, Velez‐Garcia E, Bartolucci A, Wirtschafter D, Dorfman R. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease Cancer. 42: 2101-2110. PMID 719600 DOI: 10.1002/1097-0142(197811)42:5<2101::Aid-Cncr2820420504>3.0.Co;2-M |
0.349 |
|
| 1977 |
Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S. A comparison of cyclophosphamide, adriamycin, 5‐fluorouracil (CAF) and cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project Cancer. 40: 625-632. PMID 329975 DOI: 10.1002/1097-0142(197708)40:2<625::Aid-Cncr2820400206>3.0.Co;2-M |
0.315 |
|
| Show low-probability matches. |